Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity Disorder

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.40, Iss.10, 2001-01, pp. : 753-772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Considerations in the Treatment of Attention-Deficit Hyperactivity Disorder with Methylphenidate

By Wolraich M.L. Doffing M.A.

CNS Drugs, Vol. 18, Iss. 4, 2004-01 ,pp. : 243-250

Adis International

Access to resources Recommend Favorite

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder

By Ermer James C.

CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. : 1009-1025

Adis International

Access to resources Recommend Favorite

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder: Implications for Research and Treatment

By Lepping Peter

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

By Stiefel Gary

Drug Safety, Vol. 33, Iss. 10, 2010-10 ,pp. : 821-842

Adis International

Access to resources Recommend Favorite